Breaking News Instant updates and real-time market news.

NGVT

Ingevity

$98.87

0.64 (0.65%)

04:55
08/15/18
08/15
04:55
08/15/18
04:55

Ingevity management to meet with Loop Capital

Meeting to be held in Chicago on August 15 hosted by Loop Capital.

  • 15

    Aug

NGVT Ingevity
$98.87

0.64 (0.65%)

07/13/18
KEYB
07/13/18
NO CHANGE
Target $95
KEYB
Overweight
Ingevity price target raised to $95 from $90 at KeyBanc
KeyBanc analyst Michael Sison reiterated an Overweight rating on Ingevity and raised his price target to $95, telling investors in a research note that he believes both Performance Materials and Performance Chemicals are gaining momentum, with good visibility ahead giving him confidence in his 2018E EPS outlook.
07/17/18
JEFF
07/17/18
NO CHANGE
Target $102
JEFF
Buy
Ingevity price target raised to $102 from $92 at Jefferies
Jefferies analyst Daniel Rizzo raised his price target for Ingevity to $102 citing the earnings benefit of five China provinces adopting fuel standards early. China's national adoption of the Tier II fuel vapor emissions standard is still set for mid-2020, but five provinces, representing 25% of Chinese car production, will enact the higher standard in 2019, Rizzo tells investors in a research note. The analyst expects the increase in the Chinese standards to add 45c to Ingevity's earnings per share in 2019 and 2020, and thinks the stock valuation could re-rate "as these announcements validate the fuel vapor growth opportunity." He keeps a Buy rating on Ingevity.
07/18/18
LOOP
07/18/18
NO CHANGE
Target $89
LOOP
Hold
Ingevity price target raised to $89 from $83 at Loop Capital
Loop Capital analyst Chris Kapsch raised his price target on Ingevity to $89 and kept his Hold rating, saying that while the company has been a "great fundamental story" since its inception, the recent stock price appreciation is hard to justify. The analyst acknowledges that Ingevity's increased earnings power, driven by the adoption of "more rigorous evaporative emission standards in China", is becoming more visible, but contends that the adoption had been reflected in the valuation prior to the 2019 estimates when it is set to take place.
07/26/18
OPCO
07/26/18
NO CHANGE
Target $100
OPCO
Outperform
Ingevity price target raised to $100 from $90 at Oppenheimer
Oppenheimer analyst Ian Zaffino raised his price target for Ingevity to $100 from $90 after the company delivered better than expected Q2 results, helped by continued robust organic growth, favorable price/mix, and strong productivity. The analyst reiterates an Outperform rating on the shares.

TODAY'S FREE FLY STORIES

RCII

Rent-A-Center

$14.45

-0.03 (-0.21%)

06:55
12/18/18
12/18
06:55
12/18/18
06:55
Hot Stocks
Breaking Hot Stocks news story on Rent-A-Center »

Rent A Center trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNDR

Schneider National

$19.12

-0.015 (-0.08%)

06:54
12/18/18
12/18
06:54
12/18/18
06:54
Downgrade
Schneider National rating change  »

Schneider National…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BP

BP

$38.41

-0.25 (-0.65%)

06:53
12/18/18
12/18
06:53
12/18/18
06:53
Initiation
BP initiated  »

BP initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QCOM

Qualcomm

$56.99

-0.63 (-1.09%)

, AAPL

Apple

$164.05

-1.43 (-0.86%)

06:52
12/18/18
12/18
06:52
12/18/18
06:52
Periodicals
Qualcomm believes Apple is still violating Chinese court order, Reuters reports »

Qualcomm (QCOM) thinks…

QCOM

Qualcomm

$56.99

-0.63 (-1.09%)

AAPL

Apple

$164.05

-1.43 (-0.86%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APHB

AmpliPhi

$0.16

-0.0264 (-14.13%)

06:52
12/18/18
12/18
06:52
12/18/18
06:52
Hot Stocks
AmpliPhi announces scales up manufacturing process for AB-SA01 »

AmpliPhi Biosciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DEI

Douglas Emmett

$34.06

-1.39 (-3.92%)

06:52
12/18/18
12/18
06:52
12/18/18
06:52
Downgrade
Douglas Emmett rating change  »

Douglas Emmett downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NSC

Norfolk Southern

$147.63

-3.18 (-2.11%)

06:52
12/18/18
12/18
06:52
12/18/18
06:52
Upgrade
Norfolk Southern rating change  »

JPMorgan upgrades Norfolk…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LLY

Eli Lilly

$108.36

-3.59 (-3.21%)

06:51
12/18/18
12/18
06:51
12/18/18
06:51
Hot Stocks
Eli Lilly announces subgroup data from MONARCH 2, MONARCH 3 trials published »

Eli Lilly announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

LXFR

Luxfer

$21.42

-1.26 (-5.56%)

06:50
12/18/18
12/18
06:50
12/18/18
06:50
Conference/Events
Luxfer to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

ELY

Callaway Golf

$15.53

-1.11 (-6.67%)

06:50
12/18/18
12/18
06:50
12/18/18
06:50
Upgrade
Callaway Golf rating change  »

Callaway Golf upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KSU

Kansas City Southern

$95.83

-0.86 (-0.89%)

06:48
12/18/18
12/18
06:48
12/18/18
06:48
Downgrade
Kansas City Southern rating change  »

JPMorgan downgrades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PGTI

PGT Innovations

$16.18

-0.23 (-1.40%)

06:45
12/18/18
12/18
06:45
12/18/18
06:45
Initiation
PGT Innovations initiated  »

PGT Innovations initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CI

Cigna

$198.63

-6.71 (-3.27%)

, INFO

IHS Markit

$48.56

-0.27 (-0.55%)

06:45
12/18/18
12/18
06:45
12/18/18
06:45
Recommendations
Cigna, IHS Markit, Humana analyst commentary  »

Cigna, IHS Markit added…

CI

Cigna

$198.63

-6.71 (-3.27%)

INFO

IHS Markit

$48.56

-0.27 (-0.55%)

HUM

Humana

$303.84

3.43 (1.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Jan

  • 10

    Jan

  • 15

    Jan

PM

Philip Morris

$81.39

-1.15 (-1.39%)

, BTI

British American Tobacco

$32.73

-0.36 (-1.09%)

06:42
12/18/18
12/18
06:42
12/18/18
06:42
Downgrade
Philip Morris, British American Tobacco, Imperial Brands rating change  »

Philip Morris downgraded…

PM

Philip Morris

$81.39

-1.15 (-1.39%)

BTI

British American Tobacco

$32.73

-0.36 (-1.09%)

IMBBY

Imperial Brands

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Jan

  • 16

    Jan

  • 17

    Jan

CTRP

Ctrip

$27.31

-0.86 (-3.05%)

06:42
12/18/18
12/18
06:42
12/18/18
06:42
Periodicals
Ctrip CEO says U.S. trade dispute impacted tourism, FT reports »

Ctrip CEO Jane Sun said…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

NAV

Navistar

$23.84

-1.93 (-7.49%)

06:37
12/18/18
12/18
06:37
12/18/18
06:37
Earnings
Navistar sees FY19 revenue $10.75B-$11.25B, consensus $10.57B »

Sees FY19 adjusted EBITDA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

GD

General Dynamics

$163.43

-5.47 (-3.24%)

06:36
12/18/18
12/18
06:36
12/18/18
06:36
Periodicals
General Dynamics warns Canada over scrapping Saudi deal, Reuters reports »

General Dynamics Canadian…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

DPW

DPW Holdings

$0.14

-0.0138 (-9.21%)

06:34
12/18/18
12/18
06:34
12/18/18
06:34
Hot Stocks
DPW Holdings authorizes pursuit of IPO for DPW Technology Group »

DPW Holdings announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NAV

Navistar

$23.84

-1.93 (-7.49%)

06:34
12/18/18
12/18
06:34
12/18/18
06:34
Earnings
Navistar reports Q4 EPS $1.89, consensus $1.71 »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

CNCE

Concert Pharmaceuticals

$13.69

0.16 (1.18%)

, ACRS

Aclaris Therapeutics

$6.99

-0.31 (-4.25%)

06:33
12/18/18
12/18
06:33
12/18/18
06:33
Recommendations
Concert Pharmaceuticals, Aclaris Therapeutics analyst commentary  »

Concert remains…

CNCE

Concert Pharmaceuticals

$13.69

0.16 (1.18%)

ACRS

Aclaris Therapeutics

$6.99

-0.31 (-4.25%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CPK

Chesapeake Utilities

$87.88

-5.12 (-5.51%)

06:32
12/18/18
12/18
06:32
12/18/18
06:32
Hot Stocks
Chesapeake Utilities subsidiary acquires propane operating assets in PA »

Chesapeake Utilities…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SMSI

Smith Micro

$1.97

-0.11 (-5.29%)

06:32
12/18/18
12/18
06:32
12/18/18
06:32
Hot Stocks
Smith Micro to acquire ISM Connect Smart Retail suite for $9.8M »

Smith Micro Software…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EPZM

Epizyme

$5.94

0.08 (1.37%)

, GSK

GlaxoSmithKline

$37.07

-0.54 (-1.44%)

06:32
12/18/18
12/18
06:32
12/18/18
06:32
Hot Stocks
Epizyme earns $8M milestone payment from GlaxoSmithKline »

Epizyme (EPZM) announced…

EPZM

Epizyme

$5.94

0.08 (1.37%)

GSK

GlaxoSmithKline

$37.07

-0.54 (-1.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FLS

Flowserve

06:29
12/18/18
12/18
06:29
12/18/18
06:29
Downgrade
Flowserve rating change  »

Flowserve downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ITW

Illinois Tool Works

$128.13

-2.89 (-2.21%)

06:29
12/18/18
12/18
06:29
12/18/18
06:29
Downgrade
Illinois Tool Works rating change  »

Illinois Tool Works…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.